Thus, the cytotoxic activity of CAR-T cells was directed only against tumor cells in which both EpCAM (or B7-H3) and ROR1 antigens were present, with no detrimental effect on normal ROR1+ cells (108) (Supplementary Table 1). The gene discussed is ROR1; the disease is neoplasm.